Aspen Aerogels (ASPN) Misses Q3 EPS by 11c, Beats on Revenue; Offers FY24 Revenue Guidance
Tweet
Share
E-mailGet Alerts ASPN Hot Sheet
Price: $6.07 -1.3%
Financial Fact:
Total other expense: -547.85K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total other expense: -547.85K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.17), $0.11 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $117.3 million versus the consensus estimate of $107.85 million.
GUIDANCE:
Aspen Aerogels sees FY2024 revenue of $450 million, versus the consensus of $415.2 million.
For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- JPMorgan Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- UBS Upgrades Pagegroup Plc. (PAGE:LN) (MPGPY) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
